MEDICO REMEDIES
|
MEDICO REMEDIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 1.58 | 1.22 | 1.00 | 0.87 | 2.90 |
| CEPS(Rs) | 1.95 | 1.58 | 1.35 | 1.20 | 0.85 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 9.10 | 7.53 | 6.31 | 5.28 | 22.04 |
| Tax Rate(%) | 27.38 | 25.26 | 26.86 | 28.29 | 25.78 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 8.25 | 9.55 | 8.91 | 6.75 | 6.06 |
| EBIT Margin(%) | 9.63 | 9.71 | 8.39 | 7.72 | 5.90 |
| Pre Tax Margin(%) | 8.75 | 8.95 | 7.82 | 7.19 | 5.36 |
| PAT Margin (%) | 6.35 | 6.69 | 5.72 | 5.16 | 3.98 |
| Cash Profit Margin (%) | 7.85 | 8.69 | 7.71 | 7.09 | 5.81 |
| Performance Ratios | |||||
| ROA(%) | 9.62 | 9.27 | 8.85 | 8.63 | 6.24 |
| ROE(%) | 19.02 | 17.58 | 17.23 | 18.01 | 13.94 |
| ROCE(%) | 23.28 | 21.65 | 21.90 | 21.88 | 15.09 |
| Asset Turnover(x) | 1.51 | 1.39 | 1.55 | 1.67 | 1.57 |
| Sales/Fixed Asset(x) | 4.57 | 3.53 | 3.62 | 3.95 | 3.95 |
| Working Capital/Sales(x) | 4.02 | 3.78 | 4.65 | 6.10 | 6.23 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.22 | 0.28 | 0.28 | 0.25 | 0.25 |
| Receivable days | 123.07 | 129.15 | 107.96 | 86.40 | 87.18 |
| Inventory Days | 50.18 | 52.07 | 45.38 | 49.13 | 49.25 |
| Payable days | 120.69 | 131.82 | 119.19 | 120.01 | 135.32 |
| Valuation Parameters | |||||
| PER(x) | 20.65 | 42.83 | 49.32 | 85.61 | 5.79 |
| PCE(x) | 16.71 | 32.94 | 36.61 | 62.23 | 19.83 |
| Price/Book(x) | 3.59 | 6.92 | 7.81 | 14.14 | 3.81 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.39 | 2.95 | 2.87 | 4.47 | 1.22 |
| EV/Core EBITDA(x) | 12.54 | 25.16 | 27.63 | 46.22 | 15.77 |
| EV/EBIT(x) | 14.49 | 30.36 | 34.18 | 57.82 | 20.67 |
| EV/CE(x) | 3.05 | 5.83 | 7.03 | 12.07 | 1.88 |
| M Cap / Sales | 1.31 | 2.86 | 2.82 | 4.41 | 1.15 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 36.73 | 4.15 | 3.19 | 16.04 | -1.12 |
| Core EBITDA Growth(%) | 29.78 | 17.65 | 10.85 | 44.89 | 49.34 |
| EBIT Growth(%) | 35.49 | 20.59 | 12.10 | 51.79 | 54.66 |
| PAT Growth(%) | 29.94 | 21.74 | 14.49 | 50.49 | 85.79 |
| EPS Growth(%) | 29.94 | 21.74 | 14.50 | -69.90 | -53.54 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.25 | 0.22 | 0.13 | 0.18 | 0.29 |
| Current Ratio(x) | 1.66 | 1.70 | 1.70 | 1.53 | 1.49 |
| Quick Ratio(x) | 1.27 | 1.23 | 1.33 | 1.08 | 1.03 |
| Interest Cover(x) | 11.00 | 12.66 | 14.76 | 14.52 | 10.79 |
| Total Debt/Mcap(x) | 0.07 | 0.03 | 0.02 | 0.01 | 0.08 |
Compare Financial Ratios of peers of MEDICO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICO REMEDIES | ₹290.6 Cr | 0.5% | -15.3% | -9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
MEDICO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICO REMEDIES | 0.5% |
-15.3% |
-9% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses
